Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Specialty Pharmaceuticals: Solving the Encore Problem

This article was originally published in Start Up

Executive Summary

Even the most successful specialty pharmas hit a point where an in-licensing candidate has to be almost too costly in order to sustain the growth of the organization. Start-ups are trying to avoid this trap by developing capabilities that add significant value to an in-licensing candidate, or by having at the outset some approach to identifying products and niches that no one else can.
Advertisement

Related Content

The $500 Threshold Under Medicare
Sention Inc.
Sention Inc.

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC090533

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel